DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.
Raisio chief executive officer Matti Rihko tells us he is moving onto a new venture later this year and was proud to have overseen Raisio’s transition from a challenged regional player into a “profitable international brandhouse” in his 10 years at the...
GNC could become the latest vitamin and supplement firm to have Chinese owners, with The Wall Street Journal reporting that the company has met with several interested parties.
A final report by an independent review panel on how to streamline regulations in Australia’s complementary medicines sector has stressed the importance of cutting red tape.
On the back of a deal with a ‘strong’ equity partner, Barentz International will use the additional funds to accelerate growth in its key markets in Europe, India, China and Asia Pacific, it said.
Canadian biotechnology company Neptune has followed its krill supply rivals Aker Biomarine in receiving New Food Raw Material certification in China, which allows the companies to sell their krill oil nutraceutical products in the county.
Norwegian firm Kappa Bioscience has announced a research project into possible solutions to stability issues concerning vitamin K2, results of which could help manufacturers secure label claims.
Increasing demand for industry to produce healthier foods helped Novozymes to a strong 2012 performance in its food and drink business, however the Danish enzyme specialist says growth was ‘below expectation’.
French industrial business Groupe Caravelle has said it intends to acquire an equity stake in Naturex, following Spanish group Natraceutical’s sale of its 15.35% stake in the company earlier this month.
Natural ingredients supplier Naturex has reported a healthy 15% growth in sales for the first half of its financial year on the back of ‘positive contributions’ from the firm’s new acquisitions.
UK firm Provexis is putting sports gels at the front of a revamp of the Science in Sport (SiS) supplements brand it bought for about €10m halfway through 2011.
Finnish supplier Raisio has turned in a bumper half-year with earnings before interest, tax and depreciation (EBIT) surging from €10.3m to €16.2m – a 73% rise.
Dupont, which earlier in the year warned that its May $6.49bn acquisition of Danisco would dent its yearly profits, has defied expectations in second quarter results published today.
Naturex will expand again in 2011 with several “€5-20m” targets, 1.5 years after completing the €110m integration of Spanish supplier Natraceutical that made the French botanical extracts supplier the biggest in the world.
German supplier Cognis improved EBITDA performance by 67.5 per cent in the first half of 2010- but its nutrition and health division lagged behind the performance of its household chemicals and personal care divisions.
The Irish Food Board (Board Bia) is urging Irish food manufacturers to take risks and experiment in product development by utilising the kind of “regional centres of competition” that helped make Silicon Valley in California the nexus of global software...
DSM Ventures decision to sell 33m shares and reduce its stake in UK biotech start-up Provexis from 20.8 to 17.8 per cent, represents profit-making rather than any kind of fire sale, according to an analyst.
Swedish probiotics player, Probi, is pursuing “unofficial” dialogue with the European Food Safety Authority (EFSA) after the scientific agency closed the formal process by rejecting its probiotic health claim appeal.
Frutarom has reported a rise in net profit of 6.3 per cent to US$10m in the third quarter of this year and pledged to continue its acquisition strategy.
Naturex president and chief executive officer, Jacques Dikansky, tells Shane Starling why in August the French botanicals giant bought Spanish supplier, Natraceutical Group, to double its size for the third time since 2002.
Provexis chief executive officer, Stephen Moon tells Shane Starling why becoming the first company to achieve an article 13.5 proprietary health claim has been such a boon to his company.
Naturex, the French-based botanicals giant that recently acquired the ingredients business of Spanish company, Natraceutical Group, will earn €185m in 2009 – up from its 2008 income of €93.2m, as it announced details of the deal.
Danish supplier, Danisco, has signed the Copenhagen Communiqué on Climate Change, an international measure to coordinate green measures such as carbon cutting.
Martek Biosciences is joining forces with petrochemicals giant BP to develop microbial biofuels derived from sugar feedstocks, and employing Martek’s lipid-based technologies.
Archer Daniels Midland (ADM) has reported an 83 percent decline in net earnings for Q4 2009, and in corn processing increased profits from corn-based starches and sweeteners were buried by losses in ethanol.
Bjørn Refsum, chief executive officer at leading omega-3 supplier EPAX talks to Shane Starling about the benefits vertical integration has brought to the Norwegian supplier.
Probi, a Swedish probiotic specialist and major functional dairy, Skånemejerier, are teaming up to debut a probiotic beverage to complement a probiotic juice, ProViva, they have had on-market since 1994.
Phytopharm, the UK start-up Unilever dumped in November after spending more than €20m euros in a failed attempt to develop a hoodia-based weight management product, says it is in discussions with major food and food supplements players about the South...
A provider of proprietary developments for nutraceutical and cosmeceutical ingredients has extended an existing cooperation for discovering new functional materials sourced from the jungles of Malaysia.
Gallic supplier, the Iranex Group, has acquired fellow French
natural extracts specialist Bio Serae Laboratories as part of a
strategic drive into the health and wellness sector.
Kraft Foods is throwing its weight behind the booming North
American probiotic market by signing a deal with a Scandinavian
probiotics specialist that will see the food giant expand its
digestive health range of foods called LiveActive.
German flavour and fragrance house Symrise has built on its interest in the food supplements area by entering a strategic partnership with UK-based Cambridge Theranostics.
Work is underway on construction of a dairy cultures production
plant that ingredients firm Chr Hansen claims will be the largest
of its kind when it becomes operational in spring 2008.
Health Sciences Group is intending to acquire specialty tea and
food company Kalahari - the first acquisition since its focus shift
from ingredients to branded finished foods and an indication of its
new, market-driven strategy.
Danish R&D company BSP Pharma will launch its shea butter
ingredient for use in joint health supplements in the US next week,
as the company seeks its first marketing partner for the
scientifically backed ingredient.
Canadian life science company, Fytokem Products Inc., a developer
of therapeutic plant extracts and bioactive molecules, announced
that it has signed a product development and licensing agreement
with Lonza Inc., the US subsidiary...
US agribusiness giant Cargill going from strength to strength this
year, as it reports earnings in the third quarter leapt from $151
million (€139 million) to $241 million this year. The privately
held firm said litigation settlements...
The US Women's Basketball Coaches Association (WBCA) has named
Accelerade, made by PacificHealth Laboratories, its official sports
drink. As part of the new partnership, PacificHealth will also
develop a nutrition education programme...
California-based nutritional supplements supplier Hauser has sold
its Shuster Laboratories division to Specialized Technology
Resources, a private company, for around $7.7 million (€7.81m) in
cash.
Nutraceutical Clinical Laboratories International said it has sold
its majority interest ownership in American Medical Specialties,
effective from 1 August 2002.
Zila, the US-based pharmaceutical and nutraceutical producer, said
it remained confident that EBITDA would grow significantly next
year after major restructuring of the business during the final
quarter of 2002.
Full-year results at US-based pharmaceutical and nutritional
product manufacturer Perrigo were helped by the addition of a
number of exceptional items, but also showed solid growth before
exceptionals.
